Snapshot

• Why JN Pharma City is iconic:
  Jawaharlal Nehru Pharma City (JN Pharma City), located near Visakhapatnam (Vizag), is India’s largest integrated pharmaceutical manufacturing cluster, spanning 2,400+ acres.
  Developed by Andhra Pradesh Industrial Infrastructure Corporation (APIIC) in collaboration with Ramky Group, this pharma-focused SEZ/DTA cluster hosts 100+ companies, including top names like Pfizer, Eisai, Hospira, Mylan (Viatris), Aurobindo, Laurus Labs, Dr. Reddy’s, and Divi’s Labs.
  It is designed as a plug-and-play pharmaceutical park with shared utilities, Zero Liquid Discharge (ZLD) facilities, and GMP-compliant infrastructure.
  
• Global Positioning:
  JN Pharma City contributes significantly to India’s API and formulation exports, serving regulated markets (US FDA, EMA) and emerging economies, positioning Vizag as India’s bulk drug capital.
  

Product & Service Range

Segment	Key Offerings
Active Pharmaceutical Ingredients (APIs)	Generic and specialty APIs, bulk drugs, intermediates
Formulations	Oral solids, injectables, ointments, syrups
Contract Manufacturing (CMO/CDMO)	API and formulation outsourcing
Biopharma & Biotech	Monoclonal antibodies, biosimilars (select facilities)
Pharma Intermediates	Chemical intermediates, key starting materials (KSMs)
Support Services	Analytical labs, R&D centers, logistics services

Cluster Strengths

Feature	Details
Largest Pharma SEZ	India’s only exclusive pharma industrial estate with SEZ and DTA zones
Integrated Utilities	CETPs, ZLD systems, solvent recovery units
Global-Scale Players	Home to MNCs and leading Indian pharma firms
Export Leadership	Supplies APIs and formulations to US, EU, Japan, and GCC
Infrastructure Backbone	Designed for compliance with US FDA, EMA, MHRA, and WHO GMP

Materials & Sustainability

• Core Materials: API raw materials, solvents, reagents, excipients, sterile packaging
  
• Innovation:
  
  • High-potency API (HPAPI) manufacturing suites
    
  • Automated formulation plants with continuous manufacturing
    
  • Green chemistry for solvent recovery and waste minimization
    
• Sustainability Initiatives:
  
  • Zero Liquid Discharge (ZLD) facilities
    
  • Common Effluent Treatment Plants (CETPs) and incinerators
    
  • Solar rooftops and energy-efficient production units
    

Cluster Infrastructure

• Industrial Estates:
  
  • Pharma City SEZ: 600+ acres for export-focused operations
    
  • Pharma City DTA: 1,800+ acres for domestic and contract manufacturing
    
• Shared Facilities:
  
  • Solvent recovery units, multi-fuel boilers, steam and power plants
    
  • Common warehousing and logistics support
    
• Institutions:
  
  • Pharmexcil (Pharmaceutical Export Promotion Council of India)
    
  • NIPER Hyderabad and Andhra University pharma research programs
    
• Connectivity:
  
  • 20 km from Visakhapatnam Port and 40 km from Vizag Airport
    
  • Rail connectivity for bulk drug and containerized cargo
    

Compliance & Certifications

Certification	Details
US FDA, EMA, MHRA	Global regulatory approvals for API/formulations
WHO GMP	WHO Good Manufacturing Practices certified plants
ISO 14001/45001	Environmental and occupational safety certifications
SEDEX/BSCI	Social compliance audits for global buyers
ICH Guidelines	ICH Q7 compliance for APIs

Production Timelines & MOQs

Product Type	R&D to Scale-Up	Commercial Lead Time	MOQ Guidance
APIs & Intermediates	6–9 months	12–18 months	1–5 MT
Formulations (Oral Solids)	6 months	Continuous	Project-based
Injectables	12 months	Continuous	Custom
CMO/CDMO Services	3–6 months	Contract-driven	As per project

Branding & Packaging

• Branding: Serialization (GS1) for traceability; DSCSA-compliant labeling
  
• Packaging: Export-grade blister packs, bulk containers, sterile packaging, cold chain systems
  
• Marketing Narrative:
  “JN Pharma City, Vizag: India’s premier pharma SEZ and bulk drug manufacturing hub, delivering APIs, formulations, and contract manufacturing solutions to global regulated markets.”
  

Quality Control (IndiaUnbox Protocol)

• API QC: HPLC, GC, LC-MS testing, impurity profiling
  
• Formulation QC: Dissolution, stability, and sterility testing
  
• Environmental QC: Effluent discharge monitoring, solvent recovery audits
  
• Export QC: ICH stability studies and validation protocols for regulated markets
  

Price Drivers

• Raw material costs (KSMs, solvents, reagents)
  
• Regulatory certification and audit expenses
  
• Solvent recovery and environmental compliance investments
  
• Scale of production (bulk vs specialty APIs)
  
• Export logistics and SEZ incentives
  

Buyer Confidence Signals

• Scale & Specialization: India’s largest pharma industrial estate with integrated infrastructure
  
• Global Regulatory Compliance: US FDA, EMA, WHO GMP-certified facilities
  
• Environmental Stewardship: ZLD and CETP facilities for sustainable pharma manufacturing
  
• Cluster Synergy: Co-location of API, formulations, and CDMO units enables efficiency
  

Strategic Location: Proximity to Vizag Port and pharma R&D institutions for global competitiveness